U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The company has market cap of $942.96 million. The Company’s clinics provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It has a 46.67 P/E ratio. As of December 31, 2016, the firm owned and operated 540 outpatient physical therapy clinics in 42 states; and managed 20 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups.
Cellect Biotechnology Ltd. (APOP) formed double bottom with $8.15 target or 7.00% below today’s $8.76 share price. Cellect Biotechnology Ltd. (APOP) has $52.58 million valuation. The stock decreased 1.90% or $0.17 during the last trading session, reaching $8.76. About 27,537 shares traded. Cellect Biotechnology Ltd. (NASDAQ:APOP) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.
Analysts await Cellect Biotechnology Ltd. (NASDAQ:APOP) to report earnings on March, 22. They expect $-0.31 EPS, down 3,000.00% or $0.30 from last year’s $-0.01 per share. After $-0.39 actual EPS reported by Cellect Biotechnology Ltd. for the previous quarter, Wall Street now forecasts -20.51% EPS growth.
The stock increased 0.20% or $0.15 during the last trading session, reaching $74.95. About 40,816 shares traded. U.S. Physical Therapy, Inc. (USPH) has risen 8.86% since January 14, 2017 and is uptrending. It has underperformed by 7.84% the S&P500.
Bard Associates Inc holds 2.12% of its portfolio in U.S. Physical Therapy, Inc. for 74,048 shares. Ct Mason owns 46,533 shares or 1.04% of their US portfolio. Moreover, Thomson Horstmann & Bryant Inc has 1.03% invested in the company for 121,655 shares. The Pennsylvania-based Alphaone Investment Services Llc has invested 0.97% in the stock. Ironwood Investment Management Llc, a Massachusetts-based fund reported 13,536 shares.
Since January 1, 0001, it had 0 insider purchases, and 7 sales for $1.58 million activity.
Analysts await U.S. Physical Therapy, Inc. (NYSE:USPH) to report earnings on June, 6. They expect $0.47 earnings per share, down 4.08% or $0.02 from last year’s $0.49 per share. USPH’s profit will be $5.91 million for 39.87 P/E if the $0.47 EPS becomes a reality. After $0.48 actual earnings per share reported by U.S. Physical Therapy, Inc. for the previous quarter, Wall Street now forecasts -2.08% negative EPS growth.